| 3041 | CITI Program | | 07/06/2022 17:51:45 | |
| 3042 | CITI Program | | 07/06/2022 17:51:59 | |
| 3043 | CITI Program | | 07/06/2022 17:52:11 | |
| 3044 | CITI Program | | 07/06/2022 17:52:27 | |
| 3045 | CITI Program | | 07/06/2022 17:52:39 | |
| 3046 | CITI Program | | 07/06/2022 17:52:52 | |
| 3047 | CITI Program | | 07/06/2022 17:53:06 | |
| 3048 | CITI Program | | 07/06/2022 17:53:19 | |
| 3049 | CITI Program | | 07/06/2022 17:53:34 | |
| 3050 | CITI Program | | 07/06/2022 17:53:48 | |
| 3051 | CITI program | | 07/06/2022 18:14:03 | |
| 3052 | Good Clinical Practice & Human Subject Protection Training Program 2021 | | 07/06/2022 18:34:10 | |
| 3053 | Good Clinical Practice & Human Subject Protection Training Program 2021 | | 07/06/2022 20:33:30 | |
| 3054 | Citi | | 08/06/2022 08:56:51 | |
| 3055 | Human Subject Protection Training | | 08/06/2022 10:18:25 | |
| 3056 | CITI program | | 08/06/2022 10:32:20 | |
| 3057 | CITI program, GCP (ICH Focus) | | 08/06/2022 10:33:54 | |
| 3058 | CITI program, Conflicts of Interest | | 08/06/2022 10:34:52 | |
| 3059 | CITI program, GCP (U.S. FDA Focus) | | 08/06/2022 10:36:13 | |
| 3060 | CITI program, GCP Clinical Trials Involving Investigational Devices | | 08/06/2022 10:37:31 | |
